ClinicalTrials.govpublic full text
Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis
respiratory syncytial virus (rsv), immunoprophylaxis, palivizumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917876
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.